MustafaDiken BioNTech AGGermany

MustafaDiken
Dr. Mustafa Diken received his Ph.D. in tumor immunology from Johannes Gutenberg University, Mainz and is currently serving as the Deputy Director of Immunotherapy Development Center at TRON and Vice President of Vaccines & Immunology at BioNTech RNA Pharmaceuticals. His research focuses on the development of novel cancer and infectious disease vaccines based on antigen-encoding messenger RNA (mRNA) and the elucidation of immunomodulatory mechanisms for immunotherapy. His other scientific interests include assay development for preclinical testing of vaccines. Dr. Diken is also the scientific program director of the Association for Cancer Immunotherapy (CIMT), a non-profit organization aimed at advancing cancer immunotherapy.

Tuesday 09 June 2026

Wednesday 10 June 2026

Time Session
08:30
09:15
This interactive session explores collaboration between industry and academia, offering practical perspectives from industry experts. Each expert will deliver a 5-minute introduction, sharing their experience, role, and insights into working across sectors. A moderator will guide the discussion with follow-up questions to deepen the conversation and surface actionable takeaways. The session then opens to the audience for an open “Ask Me Anything” Q&A, encouraging questions and active participation. Designed as a fully interactive format, the session features no slides or screens, prioritizing dialogue and direct engagement.
AndreasTrumpp Moderator HI-STEM GmbH in the German Cancer Research CenterGermany
Career Development Area